CR20130687A - PHARMACEUTICAL COMPOSITION FOR USE IN INFLAMMATION AND PAIN - Google Patents
PHARMACEUTICAL COMPOSITION FOR USE IN INFLAMMATION AND PAINInfo
- Publication number
- CR20130687A CR20130687A CR20130687A CR20130687A CR20130687A CR 20130687 A CR20130687 A CR 20130687A CR 20130687 A CR20130687 A CR 20130687A CR 20130687 A CR20130687 A CR 20130687A CR 20130687 A CR20130687 A CR 20130687A
- Authority
- CR
- Costa Rica
- Prior art keywords
- pharmaceutical composition
- inflammation
- pain
- combination
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229960004752 ketorolac Drugs 0.000 abstract 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960001929 meloxicam Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229960002702 piroxicam Drugs 0.000 abstract 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a una combinación y composición farmacéutica y particularmente a una combinación de un analgésico y un antiinflamatorio seleccionado de ketorolaco y meloxicam o piroxicam, y vehículos o excipientes farmacéuticamente aceptables. También se refiere a un proceso de fabricación de una composición farmacéutica y al uso de dicha composición para elaborar un medicamento útil para tratar los padecimientos de dolor e inflamación.The present invention relates to a combination and pharmaceutical composition and particularly to a combination of an analgesic and an anti-inflammatory selected from ketorolac and meloxicam or piroxicam, and pharmaceutically acceptable carriers or excipients. It also refers to a manufacturing process of a pharmaceutical composition and the use of said composition to make a useful medicine to treat pain and inflammation.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2011006758A MX357376B (en) | 2011-06-22 | 2011-06-22 | Pharmaceutical composition for use against inflammation and pain. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20130687A true CR20130687A (en) | 2014-02-21 |
Family
ID=47422093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20130687A CR20130687A (en) | 2011-06-22 | 2013-12-20 | PHARMACEUTICAL COMPOSITION FOR USE IN INFLAMMATION AND PAIN |
Country Status (13)
| Country | Link |
|---|---|
| AR (1) | AR086733A1 (en) |
| BR (1) | BR112013033007A2 (en) |
| CL (1) | CL2013003671A1 (en) |
| CO (1) | CO6831987A2 (en) |
| CR (1) | CR20130687A (en) |
| DO (1) | DOP2013000309A (en) |
| ES (1) | ES2441917B1 (en) |
| GT (1) | GT201300318A (en) |
| MX (1) | MX357376B (en) |
| NI (1) | NI201300142A (en) |
| PE (1) | PE20141530A1 (en) |
| RU (1) | RU2604149C2 (en) |
| WO (1) | WO2012176155A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2586607B1 (en) * | 2013-05-27 | 2017-07-20 | Farmacéuticos Rayere, S.A. | SYNERGISTIC PHARMACEUTICAL COMPOSITION OF TWO ANALGESICS WITH DIFFERENT PHARMACOCINETIC PROFILE |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196307B (en) * | 1984-10-22 | 1988-11-16 | Chiesi Farma Spa | AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM MONOHYDRATE |
| US5091182A (en) * | 1990-07-23 | 1992-02-25 | Syntex (U.S.A.) Inc. | Dispensing units for ketorolac topical gel formlations |
| US5436241A (en) * | 1994-01-14 | 1995-07-25 | Bristol-Myers Squibb Company | Topical anti-inflammatory compositions containing piroxicam |
| MXPA02010828A (en) * | 2002-11-04 | 2004-07-16 | Leopoldo Espinosa Abdala | Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain. |
| RU2237470C1 (en) * | 2003-01-27 | 2004-10-10 | Купсин Евгений Вениаминович | Combined preparation for removing symptoms of catarrhal diseases and grippe (variants) |
| US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
| MXPA04009698A (en) * | 2004-10-04 | 2006-04-05 | Maria Elena Garcia Armenta | Solid pharmaceutical formulations comprising diacereine and meloxicam. |
| WO2007148950A1 (en) * | 2006-06-20 | 2007-12-27 | Farmacéuticos Rayere, S.A. | Synergistic pharmaceutical composition of ketorolac and lysine clonixinate |
| MX2007003948A (en) * | 2007-04-02 | 2009-02-25 | World Trade Imp Export Wtie Ag | Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management. |
| US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
-
2011
- 2011-06-22 MX MX2011006758A patent/MX357376B/en active IP Right Grant
-
2012
- 2012-06-21 ES ES201390103A patent/ES2441917B1/en active Active
- 2012-06-21 BR BR112013033007A patent/BR112013033007A2/en not_active Application Discontinuation
- 2012-06-21 RU RU2013157013/15A patent/RU2604149C2/en active
- 2012-06-21 WO PCT/IB2012/053157 patent/WO2012176155A1/en not_active Ceased
- 2012-06-21 PE PE2013002871A patent/PE20141530A1/en not_active Application Discontinuation
- 2012-06-22 AR ARP120102254A patent/AR086733A1/en not_active Application Discontinuation
-
2013
- 2013-12-20 CO CO13297886A patent/CO6831987A2/en unknown
- 2013-12-20 NI NI201300142A patent/NI201300142A/en unknown
- 2013-12-20 DO DO2013000309A patent/DOP2013000309A/en unknown
- 2013-12-20 CR CR20130687A patent/CR20130687A/en unknown
- 2013-12-20 GT GT201300318A patent/GT201300318A/en unknown
- 2013-12-20 CL CL2013003671A patent/CL2013003671A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2013157013A (en) | 2015-07-27 |
| BR112013033007A2 (en) | 2017-01-31 |
| CO6831987A2 (en) | 2014-01-10 |
| AR086733A1 (en) | 2014-01-15 |
| PE20141530A1 (en) | 2014-11-12 |
| RU2604149C2 (en) | 2016-12-10 |
| ES2441917A2 (en) | 2014-02-06 |
| GT201300318A (en) | 2015-05-21 |
| ES2441917B1 (en) | 2014-11-25 |
| MX2011006758A (en) | 2013-01-10 |
| DOP2013000309A (en) | 2014-04-15 |
| CL2013003671A1 (en) | 2014-07-11 |
| ES2441917R1 (en) | 2014-02-19 |
| NI201300142A (en) | 2015-02-25 |
| WO2012176155A1 (en) | 2012-12-27 |
| MX357376B (en) | 2018-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201591751A1 (en) | TRIPEPTIDE EPOKEKETONE PROTEASE INHIBITORS | |
| SV2015005115A (en) | DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES | |
| MX2015009772A (en) | Spiro-lactam nmda receptor modulators and uses thereof. | |
| CL2015001891A1 (en) | Enclosed controlled dose dosage forms resistant to tampering; use to treat pain; and method of preparation. (divisional of the application n ° 2754-2014). | |
| CL2013000481A1 (en) | Method and to improve the efficacy and / or reduce the side effects of a suboptimally administered pharmacotherapy comprising the administration of a substituted hexitol; pharmaceutical composition; pharmaceutical combination; Use to treat proliferative diseases. | |
| CL2013000063A1 (en) | A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process. | |
| AR091876A1 (en) | PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
| BR112015009228A8 (en) | STERILE LIQUID PHARMACEUTICAL FORMULATION AND STERILE LIQUID OPHTHALMIC INTRAOCULAR DOSAGE FOR INJECTION | |
| CL2011002858A1 (en) | Use of an oral transmucosal pharmaceutical composition comprising dexmedetomidine and a pharmaceutically acceptable salt and a pharmaceutically acceptable excipient to prepare a medicament useful for treating or preventing pain. | |
| JO3326B1 (en) | Tripeptide Epoxy Ketone Protease Inhibitors | |
| UY33277A (en) | SPIRO-TETRACICLIC RING COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE | |
| EA201491039A1 (en) | COMBINATION DIACEREIN AND NONSTEROIDAL ANTI-INFLAMMATORY MEDICINES | |
| MX2022001796A (en) | METHODS AND COMPOSITIONS TO INHIBIT THE SYMPTOMS ASSOCIATED WITH VEISALGIA. | |
| CY1123695T1 (en) | PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY AGENTS AND PROCESS OF PREPARATION | |
| SV2010003773A (en) | 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME | |
| MX2014010989A (en) | AN ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS. | |
| EA201591603A1 (en) | NEW THERAPEUTIC COMBINATIONS MYRTAZAPINE FOR APPLICATION IN PAIN DISEASES | |
| DOP2013000309A (en) | PHARMACEUTICAL COMPOSITION FOR USE IN INFLAMMATION AND PAIN | |
| BR112013024196A2 (en) | gallium complexes, pharmaceutical compositions and methods of use | |
| ECSP088801A (en) | PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A KETOROLACO SALT AND VITAMINS OF COMPLEX B FOR THE TREATMENT OF NEURALGIA | |
| MX2019007950A (en) | Tripeptide epoxy ketone protease inhibitors. | |
| ECSP13012765A (en) | COMBINATION AND COMPOSITION FOR OBESITY TREATMENT | |
| CO6751242A2 (en) | Combination and composition for the treatment of obesity | |
| EA201290378A1 (en) | COMPOSITIONS CONTAINING NESTEROIDIC ANTI-INFLAMMATORY MEDICINES | |
| CL2011002933A1 (en) | Compounds derived from pharmaceutically acceptable salts of immetridine, h3 agonist; pharmaceutical composition comprising them; compound preparation procedure; pharmaceutical combination; and its use in the treatment of CNS diseases. |